Diagnosed with Alzheimer’s at 48, B.C. man describes a year of searching for answers
A Surrey man told The Canadian Press how young-onset Alzheimer’s interrupted his working life and why getting a diagnosis took about a year after he sought care.
In this article & details
A Surrey, B.C., man diagnosed with Alzheimer’s disease at 48 told The Canadian Press in an interview published Nov. 15 that about a year passed between his first visit to his doctor and confirmation of the disease. When the diagnosis came, he had to give up driving and leave his career, changes that forced his family to rethink its finances and plans for care.
When the symptoms start before age 65
He told the news agency he had started struggling with familiar tasks at work and sometimes became disoriented on the drive home. At first, he attributed the lapses to stress and a busy schedule. The Canadian Press reported that the eventual diagnosis followed testing of his cerebrospinal fluid for an Alzheimer’s biomarker.
The Alzheimer Society of Canada says young-onset dementia can be harder to recognize because clinicians may initially consider other causes of changes at this age. “Young onset” describes when symptoms begin, before 65. It does not describe the stage of the disease, and Alzheimer’s is one of several possible causes of dementia in this age group.
The society’s Landmark Study estimated that about 28,000 people younger than 65 were living with dementia in Canada in 2020. Its model projects that the figure could exceed 40,000 by 2050. Those figures cover all causes of dementia in that age group, and the latter is a projection, not a current count.
Treatment eligibility depends on diagnosis and stage
Health Canada issued a conditional authorization for lecanemab (Leqembi) in October 2025. The regulator’s qualifying notice describes an indication for certain adults with mild cognitive impairment or mild dementia due to Alzheimer’s disease, with confirmed amyloid pathology and restrictions based on ApoE ε4 status. A diagnosis before age 65 does not, by itself, determine eligibility.
As an Alzheimer Society of Ontario report highlighted this month, diagnostic testing and monitoring capacity affect access alongside drug coverage. In the Surrey man’s account, getting a name for his symptoms after a year of assessment still left his family to work through decisions about employment, finances and future care.
References
- A dementia diagnosis is devastating. What happens when you’re only 48? — The Canadian Press via CityNews, Original interview, Nov. 15, 2026
- How to get a diagnosis for young onset dementia — Alzheimer Society of Canada, Diagnostic information
- Dementia numbers in Canada — Alzheimer Society of Canada, Landmark Study estimates and projections
- Leqembi: Notice of Compliance information — Health Canada, Conditional authorization, Oct. 24, 2025
- Leqembi: Qualifying notice (273840) — Health Canada, Indication and authorization conditions